North-methanocarbathymidine
North-methanocarbathymidine (N-MCT) is a potent antiviral agent. North-methanocarbathymidine inhibits DNA synthesis. North-methanocarbathymidine demonstrates potent antiviral activity against HSV-1, HSV-2 and KSHV. North-methanocarbathymidine exhibits anticancer activity against colon adenocarcinoma expressing HSV-tk.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 156126-12-4
- Formule: C12H16N2O4
- Masse moléculaire:252.27
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform DNA/RNA Synthesis
More
Activité biologique
Description
IC50 & Target
[1]|
HSV-1 |
HSV-2 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HFF | CC50 |
>396 μM
Compound: 1a
|
Cytotoxic concentration for 50% inhibition of cell growth of HSV-1 infected HFF cells determined by CPE assay
Cytotoxic concentration for 50% inhibition of cell growth of HSV-1 infected HFF cells determined by CPE assay
|
[PMID: 14584954] |
| HFF | CC50 |
>396 μM
Compound: 1a
|
Cytotoxic concentration for 50% inhibition of cell growth of HSV-2 infected HFF cells determined by CPE assay
Cytotoxic concentration for 50% inhibition of cell growth of HSV-2 infected HFF cells determined by CPE assay
|
[PMID: 14584954] |
| HFF | CC50 |
>79 μM
Compound: 1a
|
Cytotoxic concentration for 50% inhibition of cell growth of HSV-1 infected HFF cells determined by VPR assay
Cytotoxic concentration for 50% inhibition of cell growth of HSV-1 infected HFF cells determined by VPR assay
|
[PMID: 14584954] |
| HFF | CC50 |
>79 μM
Compound: 1a
|
Cytotoxic concentration for 50% inhibition of cell growth of HSV-2 infected HFF cells determined by VPR assay
Cytotoxic concentration for 50% inhibition of cell growth of HSV-2 infected HFF cells determined by VPR assay
|
[PMID: 14584954] |
| HFF | EC50 |
0.04 μM
Compound: 1a
|
Inhibitory concentration for HSV-1 plaque reduction (VPR) by 50% in HFF cells
Inhibitory concentration for HSV-1 plaque reduction (VPR) by 50% in HFF cells
|
[PMID: 14584954] |
| HFF | EC50 |
0.12 μM
Compound: 1a
|
Inhibitory concentration required to reduce HSV-1 induced cytopathogenic effect (CPE) by 50 % in HFF cells
Inhibitory concentration required to reduce HSV-1 induced cytopathogenic effect (CPE) by 50 % in HFF cells
|
[PMID: 14584954] |
| HFF | EC50 |
0.35 μM
Compound: 1a
|
Inhibitory concentration required to reduce HSV-2 induced cytopathogenic effect (CPE) by 50 % in HFF cells
Inhibitory concentration required to reduce HSV-2 induced cytopathogenic effect (CPE) by 50 % in HFF cells
|
[PMID: 14584954] |
| HFF | EC50 |
0.47 μM
Compound: 1a
|
Inhibitory concentration for HSV-2 plaque reduction (VPR) by 50% in HFF cells
Inhibitory concentration for HSV-2 plaque reduction (VPR) by 50% in HFF cells
|
[PMID: 14584954] |
Chemical Information
-
CAS No. 156126-12-4
-
Masse moléculaire 252.27
-
Formule C12H16N2O4
-
SMILES
O=C1NC(C(C)=CN1[C@@H]2[C@@]3([H])C[C@@]3(CO)[C@@H](O)C2)=O
-
Synonyms
N-MCT
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)